NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · IEX Real-Time Price · USD
0.133
0.00 (-0.23%)
At close: Apr 18, 2024, 3:59 PM
0.138
+0.005 (4.14%)
After-hours: Apr 18, 2024, 6:34 PM EDT
NLS Pharmaceutics AG Market Cap
NLS Pharmaceutics AG has a market cap or net worth of $5.25 million as of April 18, 2024. Its market cap has decreased by -80.19% in one year.
Market Cap
5.25M
Enterprise Value
3.60M
1-Year Change
-80.19%
Ranking
Category
Stock Price
$0.13
Market Cap Chart
Since the IPO on January 29, 2021, NLS Pharmaceutics AG's market cap has decreased from $48.88M to $5.25M, a decrease of -89.26%. That is a compound annual growth rate of -50.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2024 | 4.70M | -4.08% |
| Apr 16, 2024 | 4.90M | -2.00% |
| Apr 15, 2024 | 5.00M | -7.41% |
| Apr 12, 2024 | 5.40M | -1.82% |
| Apr 11, 2024 | 5.50M | 1.85% |
| Apr 10, 2024 | 5.40M | 1.89% |
| Apr 9, 2024 | 5.30M | 6.00% |
| Apr 8, 2024 | 5.00M | -1.96% |
| Apr 5, 2024 | 5.10M | -7.27% |
| Apr 4, 2024 | 5.50M | -3.51% |
| Apr 3, 2024 | 5.70M | -9.52% |
| Apr 2, 2024 | 6.30M | 3.28% |
| Apr 1, 2024 | 6.10M | -4.69% |
| Mar 28, 2024 | 6.40M | 8.47% |
| Mar 27, 2024 | 5.90M | -4.84% |
| Mar 26, 2024 | 6.20M | 5.08% |
| Mar 25, 2024 | 5.90M | -7.81% |
| Mar 22, 2024 | 6.40M | 4.92% |
| Mar 21, 2024 | 6.10M | 8.93% |
| Mar 20, 2024 | 5.60M | -41.67% |
| Mar 19, 2024 | 9.60M | - |
| Mar 18, 2024 | 9.60M | -12.73% |
| Mar 15, 2024 | 11.00M | -8.33% |
| Mar 14, 2024 | 12.00M | -1.64% |
| Mar 13, 2024 | 12.20M | 3.39% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintara Therapeutics | 5.67M |
| PaxMedica | 5.63M |
| Silo Pharma | 5.56M |
| Azitra | 5.49M |
| GT Biopharma | 5.48M |
| Kineta | 5.37M |
| Sonnet BioTherapeutics Holdings | 5.34M |
| Hoth Therapeutics | 5.33M |